Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2003
08/07/2003US20030147847 Isolated nucleic acid encoding a protein comprising a glycosylphosphatidyl inositol-1 polypeptide can enhance the cytolytic activity of peripheral blood mononuclear cells
08/07/2003US20030147846 Methods of using macrophage inflammatory protein-4 (MIP-4) and myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptides
08/07/2003US20030147809 Antitumor agents
08/07/2003US20030147808 Single Chain Fv constructs of anti-ganglioside GD2 antibodies
08/07/2003US20030147806 PSCA: prostate stem cell anitgen and uses thereof
08/07/2003CA2849427A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
08/07/2003CA2509776A1 Vaccine adjuvant based on a cd40 ligand
08/07/2003CA2474908A1 Aggrecanase molecules
08/07/2003CA2474759A1 Gene for peripheral arterial occlusive disease
08/07/2003CA2474649A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003CA2474616A1 Human monoclonal antibodies to prostate specific membrane antigen (psma)
08/07/2003CA2474567A1 Amidases, nucleic acids encoding them and methods for making and using them
08/07/2003CA2474497A1 Compositions and methods related to tim-3, a th1-specific cell surface molecule
08/07/2003CA2474240A1 Novel monoclonal antibody and nematode larval antigens
08/07/2003CA2473994A1 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
08/07/2003CA2473810A1 Fgfr agonists
08/07/2003CA2469571A1 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
08/07/2003CA2466025A1 Rsv proteins, antibodies, compositions, methods and uses
08/07/2003CA2464869A1 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases
08/06/2003EP1333094A2 Human telomerase catalytic subunit
08/06/2003EP1333093A2 Human muscle nad: arginine adpribosyltransferase
08/06/2003EP1333035A2 Growth differentiation factor-8
08/06/2003EP1333032A1 Method of purifying antibody
08/06/2003EP1333023A1 Haptens, immunogens, antibodies and conjugates to ketamine and its metabolites
08/06/2003EP1332761A1 Agonists of fibroblast growth factor receptors (FGFR)
08/06/2003EP1332760A1 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
08/06/2003EP1332371A2 Method to identify antibody targets based on mass spectrometry (maldi-tof)
08/06/2003EP1332157A2 Prokineticin polypeptides, related compositions and methods
08/06/2003EP1332156A2 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods
08/06/2003EP1332154A1 Novel therapeutic compositions for treating infection by lawsonia spp
08/06/2003EP1331944A1 Use of cd28-specific monoclonal antibodies for stimulating blood cells that lack cd28
08/06/2003EP1331943A2 Nucleic acid molecules and polypeptides for immune modulation
08/06/2003EP1331942A2 Immunogen comprising ligand bound hiv envelope protein
08/06/2003EP0702563B1 Compositions and methods for treating cancer and hyperproliferative disorders
08/06/2003CN1434865A Regulation effect of conjugated frame transport protein ABC1
08/06/2003CN1434832A DNA for encoding the RGI polypeptide
08/06/2003CN1434722A Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
08/06/2003CN1434718A Activation and inhibition of immune system
08/06/2003CN1117160C Process for the preparation of recombinant proteins in E coli by high cell density fermentation
08/06/2003CN1117155C Novel compounds
08/06/2003CN1117150C EB virus DNA sequences encoding diagnostically releavant virus capid antigen expression clones derived through polymerase chain reaction and use of this recombinant antigen in diagnostic
08/06/2003CN1117148C Vaccineforinfections agents, compositions for treating and preventing HIV infections
08/06/2003CN1116869C Use of THF-alpha-antagonist for treating neurogenic skin redness
08/05/2003US6602993 Nuclelotide sequences coding peptide for use in the treatment of autoimmune diseases
08/05/2003US6602986 Antibody comprising a heavy and light chain, each comprising three nonnaturally occuring chain determining regions; antibody specifically binds to human antigen
08/05/2003US6602984 Human elastase IV
08/05/2003US6602853 Antigenic peptides reacting with anti-ovary antibodies
08/05/2003US6602707 Mammalian cell surface DNA receptor-encoding nucleic acid
08/05/2003US6602688 Transforming a thioredoxin reductase-deficient Escherichia strain with a nucleotide molecule encoding antibody; culturing; enzyme cleaves nontoxic prodrug to give the toxic drug; antitumor agent
08/05/2003US6602687 Culturing bacterial cells transformed with a bacterial expression vector comprising given DNA sequence; may be used in the treatment of neurological disorders, such as Alzheimer's disease, and treating spinal cord damage
08/05/2003US6602684 Culturing a host cell to express a nucleic acid encoding beta (1,4)-N- acetylglucosaminyltransferase III under conditions for production of a polypeptide; can use to provide proteins with improved therapeutic properties
08/05/2003US6602683 Biologically active Eph family ligands
08/05/2003US6602667 Of given sequence; useful for diagnosis, prognosis, treatment of inflammatory disorders; screening to identify ligands which bind the polynucleotides
08/05/2003US6602505 Polynucleotide comprising caprine arthritis encephalitis virus (CAEV) viral genome renders nonpathogenic to a primate a resulting retroviral particle produced via gene expression, generating immune response against HIV-1
08/05/2003US6602504 Useful in prophylaxis, therapy, and diagnosis of infections in canines
08/05/2003US6602503 Complementarity determining regions (CDRs); asthma and inflammatory bowel disease; integrins; antigen binding regions derived from the heavy and/ or light chain variable regions
08/05/2003US6602501 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
08/05/2003CA2228590C Cerebellum-derived growth factors, and uses related thereto
07/2003
07/31/2003WO2003062825A1 DIAGNOSTIC TEST METHOD FOR DETECTION OF THE GM ALLOTYPE G2m(n)
07/31/2003WO2003062446A2 Mrp9 and its use detecting and treating cancer
07/31/2003WO2003062428A1 Genetic sequences having methyltransferase activity and uses therefor
07/31/2003WO2003062415A2 Transgenic animal comprising intracellular immunoglobins for xenotransplantation
07/31/2003WO2003062375A2 Stabilizing polypeptides which have been exposed to urea
07/31/2003WO2003062370A2 Multimeric proteins and methods of making and using same
07/31/2003WO2003062278A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
07/31/2003WO2003062277A1 Corticotropin releasing factor receptor 2 agonists
07/31/2003WO2003062275A1 Glycoisoforms of adiponectin and uses thereof
07/31/2003WO2003062274A1 Novel proteins and dnas thereof
07/31/2003WO2003062271A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
07/31/2003WO2003062270A2 Fluorescent protein from aequorea coerulscens and uses therof
07/31/2003WO2003062269A2 Corticotropin releasing factor receptor 2 agonists
07/31/2003WO2003062268A2 Corticotropin releasing factor receptor 2 agonists
07/31/2003WO2003061765A1 Method of prophylaxis against large myocardial infarctions
07/31/2003WO2003061695A1 Methods of regulating cytokine receptor signaling
07/31/2003WO2003061694A1 Immunosuppression of the humoral immune response by anti-cd20 antibodies
07/31/2003WO2003061693A1 Immunogen adherence and method of making and using same
07/31/2003WO2003061595A2 Antibodies against and compositions containing new amphetamine derivatives
07/31/2003WO2003061578A2 Compositions for treatment or prevention of bioterrorism
07/31/2003WO2003061575A2 Anti-idiotype antibody of disintegrin and uses thereof
07/31/2003WO2003061571A2 Combination il-2/anti-herz antibody therapy for cancers characterized by overexpression of the her2 receptor protein
07/31/2003WO2003061561A2 Epsilon immunoglobulin chain derived peptides for induction of anti-ige antibodies
07/31/2003WO2003061365A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
07/31/2003WO2003045978A3 Antagonist anti-cd40 monoclonal antibody therapy for multiple sclerosis treatment
07/31/2003WO2003041659A3 Method and identification of downstream mrna ligands to fmrp and their role in fragile x syndrome and associated disorders
07/31/2003WO2003025140A3 Transductin-1 and transductin-2 and applications to hereditary deafness
07/31/2003WO2003024388A3 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
07/31/2003WO2003016333A3 Virus coat protein/receptor chimeras and methods of use
07/31/2003WO2003006607A3 Inhibition of apoptosis process and improvement of cell performance
07/31/2003WO2003006499A3 Survivin interacting protein tpr1
07/31/2003WO2003004607A3 Aggrecanase molecules
07/31/2003WO2003001870A3 Methods for making antibody fragments and compositions resulting therefrom
07/31/2003WO2003000024A3 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection
07/31/2003WO2002101005A3 A g-protein coupled receptor and uses therefor
07/31/2003WO2002100408A3 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels
07/31/2003WO2002087611A3 Agent of human origin for vaccination against gd2 positive tumours
07/31/2003WO2002086123A3 A human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
07/31/2003WO2002083849A9 Vascular endothelial growth factor 2
07/31/2003WO2002060936A3 Vaccine and compositions for the prevention and treatment of neisserial infections
07/31/2003WO2002059148A3 A method for identification, isolation and production of antigens to a specific pathogen
07/31/2003WO2002047730A3 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins